Shopping Cart 0
Cart Subtotal
USD 0

Firalis SAS - Product Pipeline Analysis, 2018 Update

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
USD 750

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
USD 1500

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
USD 2250
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase
  • Products and Companies

Details

Summary

Firalis SAS (Firalis) is a biotechnology company that develops biomarkers and biomarker-based diagnostic kits. The company's biomarker products comprise recombinant proteins and calibrants, Elisa kits, and monoclonal antibodies, among others. It offers biomarker services such as flow cytometry, metabolomics and lipidomics, proteomics, genomics and transcriptomics, biobanking services, biomarker data analysis services, assay development and biomarker regulatory consultancy services, among others. Firalis also provides research and development on cardiovascular biomarkers, personalized medicine, drug safety and efficacy, patient stratification and new biomarker technologies and solutions, among others. It also discovers and develops biomarkers related to inflammatory disorders. Firalis is headquartered in Huningue, France.

This report is a source for data, analysis, and actionable intelligence on the company's portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments

- The report analyzes all pipeline products in development for the company Firalis SAS

- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)

- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date

- The report provides detailed description of products in development, technical specification and functions

- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape

- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio

- To formulate effective Research & Development strategies

- Develop market-entry and market expansion strategies

- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return

- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline

- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

- Develop competition strategies by identifying the status and likely launch of the competitors' pipeline products through review of the clinical trials, stage and of development, etc

- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Note: Some sections may be missing if data is unavailable for the company

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents 2

List of Tables 3

List of Figures 3

Firalis SAS Company Overview 4

Firalis SAS Company Snapshot 4

Firalis SAS Pipeline Products and Ongoing Clinical Trials Overview 4

Firalis SAS - Pipeline Analysis Overview 6

Firalis SAS - Key Facts 6

Firalis SAS - Major Products and Services 7

Firalis SAS Pipeline Products by Development Stage 8

Firalis SAS Pipeline Products Overview 10

Biomarker Test - Rheumatoid Arthritis 10

Biomarker Test - Rheumatoid Arthritis Product Overview 10

Companion Diagnostic Assay - Coxibs and NSAIDs 11

Companion Diagnostic Assay - Coxibs and NSAIDs Product Overview 11

Diagnostic Assay - Cardiovascular Diseases 12

Diagnostic Assay - Cardiovascular Diseases Product Overview 12

Diagnostic Kit - Acute Myocardial Infarction 13

Diagnostic Kit - Acute Myocardial Infarction Product Overview 13

Diagnostic Kit - Drug Induced Vasculitis 14

Diagnostic Kit - Drug Induced Vasculitis Product Overview 14

Diagnostic Kit - Non Drug Induced Vasculitis 15

Diagnostic Kit - Non Drug Induced Vasculitis Product Overview 15

Diagnostic Panel - Vasculitis 16

Diagnostic Panel - Vasculitis Product Overview 16

Micro-ELISA System 17

Micro-ELISA System Product Overview 17

Peripheral Biomarker - Minimal Vasculitis 18

Peripheral Biomarker - Minimal Vasculitis Product Overview 18

Prognostic miRNA Assay - Heart Failure 19

Prognostic miRNA Assay - Heart Failure Product Overview 19

Firalis SAS - Key Competitors 20

Firalis SAS - Key Employees 21

Firalis SAS - Locations And Subsidiaries 22

Head Office 22

Other Locations & Subsidiaries 22

Recent Developments 23

Firalis SAS, Recent Developments 23

Sep 19, 2014: Firalis Inaugurated its Biomarker Production Site 23

Feb 24, 2014: Firalis gets certified according to ISO 13485 and ISO 9001 standards; for the development and production of Firalis ELISA kits 23

Jan 09, 2014: Firalis Expands Service Offerings via New Bioanalytical Platform 23

Dec 24, 2013: Firalis launched a range of CE marked immunoassays for the titration of cardiovascular markers 24

Appendix 25

Methodology 25

About GlobalData 28

Contact Us 28

Disclaimer 28


List Of Figure

List of Figures

Firalis SAS Pipeline Products by Equipment Type 5

Firalis SAS Pipeline Products by Development Stage 8


List Of Table

List of Tables

Firalis SAS Pipeline Products and Ongoing Clinical Trials Overview 4

Firalis SAS Pipeline Products by Equipment Type 5

Firalis SAS Pipeline Products by Indication 5

Firalis SAS, Key Facts 6

Firalis SAS, Major Products and Services 7

Firalis SAS Number of Pipeline Products by Development Stage 8

Firalis SAS Pipeline Products Summary by Development Stage 9

Biomarker Test - Rheumatoid Arthritis - Product Status 10

Biomarker Test - Rheumatoid Arthritis - Product Description 10

Companion Diagnostic Assay - Coxibs and NSAIDs - Product Status 11

Companion Diagnostic Assay - Coxibs and NSAIDs - Product Description 11

Diagnostic Assay - Cardiovascular Diseases - Product Status 12

Diagnostic Assay - Cardiovascular Diseases - Product Description 12

Diagnostic Kit - Acute Myocardial Infarction - Product Status 13

Diagnostic Kit - Acute Myocardial Infarction - Product Description 13

Diagnostic Kit - Drug Induced Vasculitis - Product Status 14

Diagnostic Kit - Drug Induced Vasculitis - Product Description 14

Diagnostic Kit - Non Drug Induced Vasculitis - Product Status 15

Diagnostic Kit - Non Drug Induced Vasculitis - Product Description 15

Diagnostic Panel - Vasculitis - Product Status 16

Diagnostic Panel - Vasculitis - Product Description 16

Micro-ELISA System - Product Status 17

Micro-ELISA System - Product Description 17

Peripheral Biomarker - Minimal Vasculitis - Product Status 18

Peripheral Biomarker - Minimal Vasculitis - Product Description 18

Prognostic miRNA Assay - Heart Failure - Product Status 19

Prognostic miRNA Assay - Heart Failure - Product Description 19

Firalis SAS, Key Employees 21

Firalis SAS, Other Locations 22

Glossary 27

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products and Companies

Products

Firalis SAS, Product, Pipeline, Product Pipeline, Key Pipeline, Products by Equipment Type, Equipment Type, Therapy Area, Products by Therapy Area, Development Stage, Products by Development Stage, Milestone, Products by Milestone, Major Products, Brands, No of Products, Device Class, Market, Territory, Product Name, Therapy Name, Trial Name, Trial, Indication, Summary, Event Type, Clinical Trial, MileStone, Product Status, Product Description, Description, Patent, Patent Details, Competitors, Key Employees, Subsidiaries, Locations, News, Events, Developments, medical devices, business description, company facts, trial phase, approval, estimated, technology, product patent details, phase, trial status, trial objective, trial design, trial site, business strategies, trends, pipeline and technology, sales strategies


Companies

Chelatec SAS

Alfact Innovation

SAS HCS Pharma

Ariana Pharmaceuticals SA

Vaiomer SAS

PathoQuest SAS

Bleu Medical

Algenics SAS

Societe Francaise de Radiotherapie Oncologique

Summary

Firalis SAS (Firalis) is a biotechnology company that develops biomarkers and biomarker-based diagnostic kits. The company's biomarker products comprise recombinant proteins and calibrants, Elisa kits, and monoclonal antibodies, among others. It offers biomarker services such as flow cytometry, metabolomics and lipidomics, proteomics, genomics and transcriptomics, biobanking services, biomarker data analysis services, assay development and biomarker regulatory consultancy services, among others. Firalis also provides research and development on cardiovascular biomarkers, personalized medicine, drug safety and efficacy, patient stratification and new biomarker technologies and solutions, among others. It also discovers and develops biomarkers related to inflammatory disorders. Firalis is headquartered in Huningue, France.

This report is a source for data, analysis, and actionable intelligence on the company's portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments

- The report analyzes all pipeline products in development for the company Firalis SAS

- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)

- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date

- The report provides detailed description of products in development, technical specification and functions

- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape

- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio

- To formulate effective Research & Development strategies

- Develop market-entry and market expansion strategies

- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return

- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline

- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

- Develop competition strategies by identifying the status and likely launch of the competitors' pipeline products through review of the clinical trials, stage and of development, etc

- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Note: Some sections may be missing if data is unavailable for the company

READ MORE

Scope

Table of Contents

Table of Contents 2

List of Tables 3

List of Figures 3

Firalis SAS Company Overview 4

Firalis SAS Company Snapshot 4

Firalis SAS Pipeline Products and Ongoing Clinical Trials Overview 4

Firalis SAS - Pipeline Analysis Overview 6

Firalis SAS - Key Facts 6

Firalis SAS - Major Products and Services 7

Firalis SAS Pipeline Products by Development Stage 8

Firalis SAS Pipeline Products Overview 10

Biomarker Test - Rheumatoid Arthritis 10

Biomarker Test - Rheumatoid Arthritis Product Overview 10

Companion Diagnostic Assay - Coxibs and NSAIDs 11

Companion Diagnostic Assay - Coxibs and NSAIDs Product Overview 11

Diagnostic Assay - Cardiovascular Diseases 12

Diagnostic Assay - Cardiovascular Diseases Product Overview 12

Diagnostic Kit - Acute Myocardial Infarction 13

Diagnostic Kit - Acute Myocardial Infarction Product Overview 13

Diagnostic Kit - Drug Induced Vasculitis 14

Diagnostic Kit - Drug Induced Vasculitis Product Overview 14

Diagnostic Kit - Non Drug Induced Vasculitis 15

Diagnostic Kit - Non Drug Induced Vasculitis Product Overview 15

Diagnostic Panel - Vasculitis 16

Diagnostic Panel - Vasculitis Product Overview 16

Micro-ELISA System 17

Micro-ELISA System Product Overview 17

Peripheral Biomarker - Minimal Vasculitis 18

Peripheral Biomarker - Minimal Vasculitis Product Overview 18

Prognostic miRNA Assay - Heart Failure 19

Prognostic miRNA Assay - Heart Failure Product Overview 19

Firalis SAS - Key Competitors 20

Firalis SAS - Key Employees 21

Firalis SAS - Locations And Subsidiaries 22

Head Office 22

Other Locations & Subsidiaries 22

Recent Developments 23

Firalis SAS, Recent Developments 23

Sep 19, 2014: Firalis Inaugurated its Biomarker Production Site 23

Feb 24, 2014: Firalis gets certified according to ISO 13485 and ISO 9001 standards; for the development and production of Firalis ELISA kits 23

Jan 09, 2014: Firalis Expands Service Offerings via New Bioanalytical Platform 23

Dec 24, 2013: Firalis launched a range of CE marked immunoassays for the titration of cardiovascular markers 24

Appendix 25

Methodology 25

About GlobalData 28

Contact Us 28

Disclaimer 28


List Of Figure

List of Figures

Firalis SAS Pipeline Products by Equipment Type 5

Firalis SAS Pipeline Products by Development Stage 8


List Of Table

List of Tables

Firalis SAS Pipeline Products and Ongoing Clinical Trials Overview 4

Firalis SAS Pipeline Products by Equipment Type 5

Firalis SAS Pipeline Products by Indication 5

Firalis SAS, Key Facts 6

Firalis SAS, Major Products and Services 7

Firalis SAS Number of Pipeline Products by Development Stage 8

Firalis SAS Pipeline Products Summary by Development Stage 9

Biomarker Test - Rheumatoid Arthritis - Product Status 10

Biomarker Test - Rheumatoid Arthritis - Product Description 10

Companion Diagnostic Assay - Coxibs and NSAIDs - Product Status 11

Companion Diagnostic Assay - Coxibs and NSAIDs - Product Description 11

Diagnostic Assay - Cardiovascular Diseases - Product Status 12

Diagnostic Assay - Cardiovascular Diseases - Product Description 12

Diagnostic Kit - Acute Myocardial Infarction - Product Status 13

Diagnostic Kit - Acute Myocardial Infarction - Product Description 13

Diagnostic Kit - Drug Induced Vasculitis - Product Status 14

Diagnostic Kit - Drug Induced Vasculitis - Product Description 14

Diagnostic Kit - Non Drug Induced Vasculitis - Product Status 15

Diagnostic Kit - Non Drug Induced Vasculitis - Product Description 15

Diagnostic Panel - Vasculitis - Product Status 16

Diagnostic Panel - Vasculitis - Product Description 16

Micro-ELISA System - Product Status 17

Micro-ELISA System - Product Description 17

Peripheral Biomarker - Minimal Vasculitis - Product Status 18

Peripheral Biomarker - Minimal Vasculitis - Product Description 18

Prognostic miRNA Assay - Heart Failure - Product Status 19

Prognostic miRNA Assay - Heart Failure - Product Description 19

Firalis SAS, Key Employees 21

Firalis SAS, Other Locations 22

Glossary 27

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products

Firalis SAS, Product, Pipeline, Product Pipeline, Key Pipeline, Products by Equipment Type, Equipment Type, Therapy Area, Products by Therapy Area, Development Stage, Products by Development Stage, Milestone, Products by Milestone, Major Products, Brands, No of Products, Device Class, Market, Territory, Product Name, Therapy Name, Trial Name, Trial, Indication, Summary, Event Type, Clinical Trial, MileStone, Product Status, Product Description, Description, Patent, Patent Details, Competitors, Key Employees, Subsidiaries, Locations, News, Events, Developments, medical devices, business description, company facts, trial phase, approval, estimated, technology, product patent details, phase, trial status, trial objective, trial design, trial site, business strategies, trends, pipeline and technology, sales strategies


Companies

Chelatec SAS

Alfact Innovation

SAS HCS Pharma

Ariana Pharmaceuticals SA

Vaiomer SAS

PathoQuest SAS

Bleu Medical

Algenics SAS

Societe Francaise de Radiotherapie Oncologique